login
Become a member
Quick Registration
Full Registration Benefits -
Free Homepages for Doctors
Free Homepages for Hospitals
Free Homepages for Medical Conference
Free Homepages for NGO's
Personal Health Record Creation
Access to all Medical Slides
Access to all Jobs & Products Sale
Increasing Obesity and Diabetes Contribute to Drug Eluting Balloons Market Growth
The new report* suggests that the value of the market is expected to almost double by 2017, reaching a value of $127 million. This will largely be due to an increase in physician uptake as long-term clinical data is released supporting their effectiveness and as the device is adopted for new indications such as PVD. US Food and Drug Administration (FDA) product approvals over the next two to three years are also expected to boost future uptake, playing on the existing importance of the US market and the current unmet need in the interventional cardiology devices market.
Of course, with further budget cuts expected for the healthcare industry in 2012, cost and patient compliance are two additional factors promoting the use of DEBs. Offering improved efficacy and patient safety for some indications, these products have the potential to create a niche market. In fact, preliminary clinical trial results suggest that DEBs could become the standard treatment for PVD and complex lesions in the future.
GlobalData analysts suggest that PVD, Small Vessel Disease (SVD), bifurcated lesions and In-Stent Restenosis (ISR) could represent a $2 billion untapped market. This market is set to be further boosted by the complications associated with long-term antiplatelet therapy. The risks of bleeding and contraindications limit current interventions and further the potential of DEBs in the healthcare industry.
Among the products set to contribute to the growth of the DEB market is B. Braun's product, SeQuent Please, which currently accounts for the highest number of completed and ongoing clinical trials. Bayer's PACCOCATH technology has also demonstrated success in animal models and both these products are expected to receive regulatory approval in the next two to three years.
(Source - GLOBALDATA, Londn, UK)
Source-Medindia
|
|
More News on: Bariatric Surgery, Diabetic Retinopathy, Drug Toxicity, Obesity, Diabetes, Diabetic Diet, Diabetes - Essentials, Binge Eating : The Pleasure and Pain, Bulimia Nervosa, Diabetes - Self-Monitoring of Blood Glucose (SMBG)
 Comment & Contribute
|
Medwonders Health Network
- Health News Index
|
|
 | Quiz on Diabetes Are you at risk for diabetes? To find out check out our health quiz. 
|
- News Quick Links
 |
Diabetes
Complete Medindia Resources
|
| News Categories: |
| » | Report: A Lot of Americans Have No Access to Health Care |
| » | Greece Faces Humanitarian Crisis as Health Care Access Declines in EU, Doctors Group Warns |
| » | HCCI Report Says Rising Prices for Care Responsible for Increased Healthcare Costs for Privately Insured Americans |
| » | Treatment in ED is Based on Children's Insurance Status |
| » | US Spends Most on Healthcare Without Providing Superior Care |
| More Insurance News | |
|
